Advertisement
Home 2016

Archives

For healthy subjects

Prednisolone Therapy Induces Procoagulant State

0
Ten days of treatment linked to increase in peak thrombin, velocity index, PAI-1, and vWF
Pulse pressure is associated with multiple adverse cardiovascular outcomes

Pulse Pressure Linked to Multiple Adverse Cardiovascular Outcomes

0
After adjustment for multiple variables, PP linked to all outcomes except stroke, cardiovascular death
Fecal immunochemical tests can consistently detect colorectal cancer when used on an annual basis

Consistent CRC Detection Seen for Fecal Immunochemical Tests

0
Effectiveness of the test varies between 73 and 78 percent in years two through four
For children with infantile hemangiomas

Serious Propranolol ADRs Rare in Infantile Hemangioma

0
Most commonly reported adverse drug reactions were respiratory disorders
In the Veterans Affairs Diabetes Trial

Hypoglycemia, Atherosclerosis Progression Link Explored

0
Serious hypoglycemia linked to progression of CAC only in standard therapy group of VA Diabetes Trial
New guidelines

Guidelines for Appropriate Use of Cardiac Imaging in the ER

0
Appropriateness of imaging evaluated in 20 clinical scenarios for ER patients presenting with chest pain
The initiation of maintenance dialysis reflects an interplay between the care practices of physicians

At Least Three Factors Influence Timing of Dialysis Initiation

0
Factors include care practices of physicians, sources of momentum, patient-physician interactions
Dysgraphia after sertraline intake has been documented in a case report published online Jan. 21 in the Journal of Clinical Pharmacy and Therapeutics.

Dysgraphia Described After Sertraline Intake

0
Case report describes 60-year-old man with tremors and episodes of buccal dyskinesia, dysgraphia
Nearly one in seven colorectal cancer patients are under 50

About 1 in 7 Colorectal Cancer Patients Younger Than 50

0
And younger patients more likely to have advanced-stage cancer
Ivacaftor is a potential new treatment to offer children aged 2 years and older with cystic fibrosis and a CFTR gating mutation

Ivacaftor Appears Efficacious, Safe for Younger CF Patients

0
Researchers find treatment works and is well tolerated in 2- to 5-year-olds with cystic fibrosis